Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy.
Sun GY, Jing H, Wang SL, Song YW, Jin J, Fang H, Liu YP, Ren H, Tang Y, Zhao XR, Song YC, Chen SY, Yang ZB, Chen B, Tang Y, Li N, Lu NN, Qi SN, Yang Y, Li YX. Sun GY, et al. Among authors: song yc, song yw. Front Oncol. 2021 Jan 26;10:605750. doi: 10.3389/fonc.2020.605750. eCollection 2020. Front Oncol. 2021. PMID: 33575216 Free PMC article.
Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
Sun GY, Wang SL, Song YW, Jin J, Wang WH, Liu YP, Ren H, Fang H, Tang Y, Zhao XR, Song YC, Yu ZH, Liu XF, Li YX. Sun GY, et al. Among authors: song yc, song yw. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):277-285. doi: 10.1016/j.ijrobp.2020.02.633. Epub 2020 Mar 5. Int J Radiat Oncol Biol Phys. 2020. PMID: 32147519 Clinical Trial.
Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial.
Song YC, Sun GY, Fang H, Tang Y, Song YW, Hu C, Qi SN, Chen B, Jing H, Tang Y, Jin J, Liu YP, Lu NN, Li YX, Wang SL. Song YC, et al. Among authors: song yw. Front Oncol. 2021 Sep 15;11:738318. doi: 10.3389/fonc.2021.738318. eCollection 2021. Front Oncol. 2021. PMID: 34604082 Free PMC article.
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial.
Song YC, Yan XN, Tang Y, Jing H, Zhang N, Zhang J, Zhong YH, Dong LH, Wu HF, Tie J, Zhong QZ, Yang WF, Wang XH, Hou XR, Lu YF, Zhao LN, Jin J, Li YX, Wang SL. Song YC, et al. Pract Radiat Oncol. 2022 Sep-Oct;12(5):397-408. doi: 10.1016/j.prro.2021.12.018. Epub 2022 Jul 13. Pract Radiat Oncol. 2022. PMID: 36058618 Clinical Trial.
Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
Song YC, Kong J, Li N, Liu XL, Li XH, Zhu LY, Wang YW, Fang H, Jing H, Tang Y, Li YX, Wang XH, Zhang J, Wang SL. Song YC, et al. Radiother Oncol. 2023 Jun;183:109639. doi: 10.1016/j.radonc.2023.109639. Epub 2023 Mar 27. Radiother Oncol. 2023. PMID: 36990395
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case.
Song YC, Hu ZH, Yan XN, Fang H, Tang Y, Jing H, Men K, Zhang N, Zhang J, Jin J, Zhong QZ, Ma J, Yang WF, Zhong YH, Dong LH, Wang XH, Wu HF, Du XH, Hou XR, Tie J, Lu YF, Zhao LN, Li YX, Wang SL. Song YC, et al. Radiat Oncol. 2023 Nov 29;18(1):194. doi: 10.1186/s13014-023-02379-1. Radiat Oncol. 2023. PMID: 38031125 Free PMC article. Clinical Trial.
Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
Song YC, Chen SY, Zhao XR, Jing H, Fang H, Tang Y, Hu SY, Song YW, Jin J, Liu YP, Qi SN, Sun GY, Zhong QZ, Du XH, Liu J, Li YX, Wang SL. Song YC, et al. Among authors: song yw. Radiother Oncol. 2024 Oct;199:110390. doi: 10.1016/j.radonc.2024.110390. Epub 2024 Jun 17. Radiother Oncol. 2024. PMID: 38897316 Clinical Trial.
38,415 results
You have reached the last available page of results. Please see the User Guide for more information.